Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

NCT06200103 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Castration-Resistant Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
OTHER: Clinical Observation
PROCEDURE: Computed Tomography
OTHER: Gallium Ga 68 Gozetotide
DRUG: Lutetium Lu 177 Vipivotide Tetraxetan
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
PROCEDURE: Single Photon Emission Computed Tomography

Sponsor

Mayo Clinic